Histone Signatures Predict Therapeutic Efficacy in Breast Cancer.
Ontology highlight
ABSTRACT: Objective: Regulatory abnormalities caused by chromatin modifications are being increasingly recognized as contributors to cancer. While many molecularly targeted drugs have the potential to revert these modifications, their precise mechanism of action in cellular reprogramming is not known. Methods: To address this, we introduce an integrated phosphoprotein-histone-drug network (iPhDNet) approach to generate "global chromatin fingerprints of histone signatures." The method integrates proteomic/phosphoproteomic, transcriptomic and regulatory genomic data to provide a causal mechanistic network and histone signatures of drug response. Results: We demonstrate the utility of iPhDNet in identifying H3K27me3K36me3 histone mark as a key fingerprint of response, mediated by c
SUBMITTER: Mollah SA
PROVIDER: S-EPMC7207876 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
ACCESS DATA